查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1833614

2032 年温控包装市场预测：按产品类型、系统类型、可用​​性、温度范围、最终用户和地区进行的全球分析

Temperature-Controlled Packaging Market Forecasts to 2032 - Global Analysis By Product Type, System Type, Usability, Temperature Range, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球温控包装市场预计在 2025 年达到 323 亿美元，到 2032 年将达到 886 亿美元，预测期内的复合年增长率为 15.5%。

温控包装可确保在运输和储存过程中需要严格温度调节的产品的安全处理。该市场广泛应用于药品、生技药品、疫苗、生鲜食品、水产品和冷冻食品，在全球供应链中发挥关键作用。由于生技药品的成长、生鲜产品的电商配送以及更严格的安全法规，对温控包装的需求正在成长。创新技术包括智慧包装、可重复使用的解决方案和环保隔热材料。随着供应链弹性和永续性受到关注，温控包装已成为确保产品品质的关键。

DHL表示，2022年将投资4亿美元扩大其医药级温控物流，新增300万平方英尺的合规设施。

生物製药的成长

生物製药产业的扩张是温控包装市场的主要驱动力。生技药品、疫苗以及细胞和基因疗法本质上都具有挥发性，需要严格、稳定的温度控制，以确保从生产到患者整个生命週期的有效性和安全性。任何偏差都可能导致这些高价值产品失效，因此坚固的包装是供应链中不可或缺的一部分。这种依赖催生了对能够确保产品完整性的先进包装解决方案的直接且不断增长的需求，从而随着越来越多的生技药品获得监管机构核准并进入市场，推动整个市场向前发展。

包装成本高

相变材料、物联网感测器和隔热材料等先进组件的整合增加了托运商和货柜的初始投资。这些高成本对于小型製药公司和物流供应商来说尤其沉重，挤压了利润率，并限制了他们可靠地运输产品的能力。这些经济障碍正在减缓采用率，尤其是在对价格敏感的新兴市场，并持续限制产业的整体成长潜力。

永续包装解决方案

市场对可回收、可重复使用、可生物降解且不影响热性能的包装材料的需求日益增长。开发环保设计的公司，例如采用植物来源凝胶和可堆肥隔热材料的系统，能够脱颖而出，吸引註重永续性的新客户。这种转变不仅是监管方面的回应，更是与企业永续性目标相符的策略性倡议，能够在生命科学物流领域开闢重要的新收益来源和品牌知名度。

产品召回

包装系统一旦发生故障，就可能导致温度升高，危及整批高价值药品的运输，并迫使企业进行代价高昂的召回。此类事件不仅会因产品处置和包装更换而造成直接经济损失，还会对药厂和包装商造成持久的声誉损害。这会削弱客户信心，并引发监管部门的更严格审查。因此，可靠性和久经考验的性能对于在竞争激烈的市场环境中保持领先至关重要。

COVID-19的影响：

新冠疫情为温控包装市场带来了前所未有的推手。全球分发温敏型疫苗（尤其是需要超低温链条件的mRNA疫苗）的迫切性，导致对先进包装解决方案的需求激增。这场危机凸显了高韧性低温运输的战略重要性，从而加速了投资，促进了包装设计的快速创新，并提高了对物流能力的认识。这场疫情从根本上改变了产业的观点，永久提升了可靠的温控包装在全球卫生安全和供应链策略中的作用。

预测期内，绝缘托运人市场预计将成为最大的市场

由于直接运送患者和临床试验样本在不断扩展的小包裹式物流模式中发挥重要作用，预计隔热运输箱细分市场将在预测期内占据最大市场份额。这些运输箱为运输小型高价值货物（例如特殊药品和临床样本）提供了一种经济高效且灵活的解决方案。其轻量化设计和一次性使用的特性简化了最终用户的物流流程。此外，轻质高性能隔热材料的不断创新确保了其持续的市场竞争力，使其成为满足行业大部分运输需求的首选解决方案。

预计主动系统部门在预测期内将实现最高复合年增长率

预计主动系统细分市场将在预测期内实现最高成长率，这得益于运输复杂生技药品和细胞治疗产品的需求日益增长，这些产品需要严格且长时间的温度控制。与被动解决方案不同，主动系统使用外部供电组件来维持精确的温度，这对于最精密产品的国际运输和多日运输至关重要。此外，即时GPS和温度监控的集成为法规遵从性和品质保证提供了宝贵的数据线索，这不仅证明了高风险、高价值药物的高成本是合理的，也推动了市场的快速普及。

占比最大的地区：

在预测期内，北美预计将占据最大的市场份额，这得益于其强大的生物製药製造基础、全球领先的物流公司以及严格的低温运输标准法规结构。该地区是生技药品和临床试验的创新中心，对先进包装有内在的需求。此外，完善的医疗基础设施和高昂的医疗支出正在推动新型先进包装技术的快速应用。美国是大型製药和包装公司高度集中的地区，形成了协同效应的生态系统。

复合年增长率最高的地区：

预计亚太地区在预测期内将呈现最高的复合年增长率，这得益于药品产量的扩大、医疗保健可及性的改善以及基础设施的大力发展。印度和中国等国家正在崛起成为全球製药强国，而收入的成长也刺激了国内对先进的温控药品的需求。为了支持这一成长，各国政府也大力投资现代化低温运输物流。这种充满活力的环境，加上对品质和合规性的日益重视，为该全部区域加速采用温控包装解决方案提供了肥沃的土壤。

免费客製化服务：

此报告的订阅者可以使用以下免费自订选项之一：

  • 公司简介
    • 对最多三家其他市场公司进行全面分析
    • 主要企业的SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球温控包装市场（依产品类型）

  • 绝缘运输公司
  • 保温容器
  • 冷媒
    • 凝胶包
    • PCM（相变材料）
    • 干冰
    • 液态氮
  • 温度监测组件

6. 全球温控包装市场（依系统类型）

  • 主动系统
  • 被动系统

7. 全球温控包装市场（依用途）

  • 免洗系统
  • 可重复使用/可回收系统

8. 全球温控包装市场（依温度范围）

  • 冷冻（-15 度C至 -25 度C或更低）
  • 冷藏（2℃至8℃）
  • 环境温度（15°C至25°C）
  • 低温（低于-150 度C）

9. 全球温控包装市场（依最终用户）

  • 医疗保健和製药
    • 临床试验
    • 生技药品及特殊药物
    • 疫苗
    • 非处方药
  • 食品/饮料
    • 新鲜农产品
    • 肉类、家禽、鱼贝类
    • 乳製品
    • RTE
  • 化学品
  • 其他最终用户

第 10 章全球温控包装市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司概况

  • Pelican BioThermal（Peli BioThermal）
  • Sonoco ThermoSafe
  • Cold Chain Technologies
  • Cryopak
  • va-Q-tec
  • CSafe Global
  • Envirotainer
  • Sofrigam
  • Intelsius（DGP Intelsius）
  • Nordic Cold Chain Solutions
  • Tower Cold Chain Solutions
  • TemperPack
  • Sealed Air
  • Chill-Pak（Engineered Packaging/Chill-Pak）
  • CoolPac
  • Pluss Advanced Technologies
Product Code: SMRC31447

According to Stratistics MRC, the Global Temperature-Controlled Packaging Market is accounted for $32.3 billion in 2025 and is expected to reach $88.6 billion by 2032 growing at a CAGR of 15.5% during the forecast period. The Temperature-Controlled Packaging ensures safe handling of products that require strict thermal regulation during transportation and storage. Widely used in pharmaceuticals, biologics, vaccines, fresh produce, seafood, and frozen goods, this market plays a critical role in global supply chains. Demand is increasing with growth in biologics, e-commerce delivery of perishables, and stricter safety regulations. Innovations include smart packaging, reusable solutions, and eco-friendly insulation materials. As supply chain resilience and sustainability gain focus, temperature-controlled packaging is becoming indispensable for product quality assurance.

According to DHL, $400 million was invested in 2022 to expand pharma-grade temperature-controlled logistics, adding 3 million sq ft of compliant facilities.

Market Dynamics:

Driver:

Growth in Biopharmaceuticals

The expansion of the biopharmaceutical sector is a primary engine for the temperature-controlled packaging market. Biologics, vaccines, and cell and gene therapies are inherently unstable and demand strict, unbroken thermal regimes to maintain their efficacy and safety from production to patient. Any deviation can render these high-value products useless, making robust packaging a non-negotiable part of the supply chain. This dependency creates a direct and growing demand for advanced packaging solutions that can ensure product integrity, thereby propelling the entire market forward significantly as more biologics receive regulatory approval and enter the market.

Restraint:

High Packaging Costs

The integration of sophisticated components like phase change materials, IoT sensors, and insulated materials drives up the initial investment for shippers and containers. These high costs can be particularly prohibitive for smaller pharmaceutical companies and logistics providers, potentially squeezing their profit margins or limiting their ability to ship products reliably. This financial hurdle can slow down adoption rates, especially in price-sensitive emerging markets, acting as a persistent restraint on the overall growth potential of the industry.

Opportunity:

Sustainable Packaging Solutions

There is a growing market appetite for recyclable, reusable, and biodegradable packaging materials that do not compromise thermal performance. Companies that pioneer eco-friendly designs, such as systems using plant-based gels or compostable insulation, can differentiate themselves and capture a new, sustainability-conscious customer segment. This shift is not merely a regulatory response but a strategic move to align with corporate sustainability goals, opening up a significant new revenue stream and enhancing brand reputation within the life sciences logistics sector.

Threat:

Product Recalls

A single failure in the packaging system, leading to temperature excursions, can compromise an entire shipment of high-value pharmaceuticals, forcing a costly recall. Beyond immediate financial losses from destroying the product and replacing the packaging, such events inflict lasting reputational damage on both the pharmaceutical manufacturer and the packaging provider. This erodes customer trust and can trigger stringent regulatory scrutiny, making reliability and proven performance critical factors for maintaining a strong position in this high-stakes market environment.

Covid-19 Impact:

The COVID-19 pandemic served as an unprecedented catalyst for the temperature-controlled packaging market. The global urgency to distribute temperature-sensitive vaccines, particularly mRNA-based ones requiring ultra-cold chain conditions, triggered a massive surge in demand for advanced packaging solutions. This crisis underscored the strategic importance of a resilient cold chain, leading to accelerated investments, rapid innovation in packaging designs, and a heightened awareness of logistics capabilities. The pandemic fundamentally shifted industry perspectives, permanently elevating the role of reliable temperature-controlled packaging in global health security and supply chain strategy.

The insulated shippers segment is expected to be the largest during the forecast period

The insulated shippers segment is expected to account for the largest market share during the forecast period fueled by its critical role in the expanding parcel-based logistics model for direct-to-patient and clinical trial distributions. These shippers offer a cost-effective and highly flexible solution for transporting smaller, high-value consignments like specialty drugs and clinical samples. Their lightweight design and single-use nature simplify the logistics process for end-users. Furthermore, continuous innovation in lightweight, high-performance insulation materials ensures their continued relevance, making them the workhorse solution for a vast portion of the industry's shipping needs.

The active systems segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the active systems segment is predicted to witness the highest growth rate driven by the escalating need to transport complex biologics and cell therapies that require stringent, long-duration temperature control. Unlike passive solutions, active systems use externally powered components to maintain precise temperatures, making them indispensable for international and multi-day shipments of the most sensitive products. Moreover, the integration of real-time GPS and temperature monitoring provides an invaluable data trail for regulatory compliance and quality assurance, justifying their higher cost for high-risk, high-value pharmaceuticals and fueling their rapid market adoption.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share driven by robust biopharmaceutical manufacturing base, the presence of major global logistics players, and a stringent regulatory framework that mandates rigorous cold chain standards. The region is a hub for innovation in biologics and clinical trials, creating inherent demand for advanced packaging. Additionally, well-established healthcare infrastructure and high healthcare spending empower the rapid adoption of new, sophisticated packaging technologies. The concentration of leading pharmaceutical and packaging companies in the U.S. creates a synergistic ecosystem that consolidates the region's dominant position in the global market landscape.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR fueled by a powerful combination of expanding pharmaceutical production, improving healthcare access, and significant infrastructure development. Countries like India and China are emerging as global pharmaceutical powerhouses, while rising incomes are increasing domestic demand for advanced, temperature-sensitive medicines. Governments are also investing heavily in modernizing their cold chain logistics to support this growth. This dynamic environment, coupled with a growing focus on quality and compliance, creates a fertile ground for the accelerated adoption of temperature-controlled packaging solutions across the region.

Key players in the market

Some of the key players in Temperature-Controlled Packaging Market include Pelican BioThermal, Sonoco ThermoSafe, Cold Chain Technologies, Cryopak, va-Q-tec, CSafe Global, Envirotainer, Sofrigam, Intelsius (DGP Intelsius), Nordic Cold Chain Solutions, Tower Cold Chain Solutions, TemperPack, Sealed Air, Chill-Pak (Engineered Packaging / Chill-Pak), CoolPac, and Pluss Advanced Technologies.

Key Developments:

In September 2025, Pelican biothermal showcased next chapter of cold chain innovation at LogiPharma US focusing on advanced temperature-controlled packaging solutions for life sciences. They provide cost-effective thermal packaging delivering measurable ROI and expanding their portfolio through acquisition.

In March 2025, Cold Chain Technologies acquired Global Cold Chain Solutions, a leading provider of passive cold chain solutions in Australia and India, to expand its Asia-Pacific presence and capabilities.

In February 2025, CSafe Global launched the AcuTemp Plus Series passive packaging designed for cold chain pharma, clinical trials, and cell and gene therapies featuring high-performing vacuum insulated panels and phase change materials for enhanced temperature control.

Product Types Covered:

  • Insulated Shippers
  • Insulated Containers
  • Refrigerants
  • Temperature Monitoring Components

System Types Covered:

  • Active Systems
  • Passive Systems

Usabilities Covered:

  • Single-Use/Disposable Systems
  • Reusable/Returnable Systems

Temperature Ranges Covered:

  • Frozen (<= -15°C to -25°C)
  • Chilled (2°C to 8°C)
  • Ambient (15°C to 25°C)
  • Cryogenic (<= -150°C)

End Users Covered:

  • Healthcare & Pharmaceuticals
  • Food & Beverages
  • Chemicals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Temperature-Controlled Packaging Market, By Product Type

  • 5.1 Introduction
  • 5.2 Insulated Shippers
  • 5.3 Insulated Containers
  • 5.4 Refrigerants
    • 5.4.1 Gel Packs
    • 5.4.2 PCMs (Phase Change Materials)
    • 5.4.3 Dry Ice
    • 5.4.4 Liquid Nitrogen
  • 5.5 Temperature Monitoring Components

6 Global Temperature-Controlled Packaging Market, By System Type

  • 6.1 Introduction
  • 6.2 Active Systems
  • 6.3 Passive Systems

7 Global Temperature-Controlled Packaging Market, By Usability

  • 7.1 Introduction
  • 7.2 Single-Use/Disposable Systems
  • 7.3 Reusable/Returnable Systems

8 Global Temperature-Controlled Packaging Market, By Temperature Range

  • 8.1 Introduction
  • 8.2 Frozen (<= -15°C to -25°C)
  • 8.3 Chilled (2°C to 8°C)
  • 8.4 Ambient (15°C to 25°C)
  • 8.5 Cryogenic (<= -150°C)

9 Global Temperature-Controlled Packaging Market, By End User

  • 9.1 Introduction
  • 9.2 Healthcare & Pharmaceuticals
    • 9.2.1 Clinical Trials
    • 9.2.2 Biologics and Specialty Drugs
    • 9.2.3 Vaccines
    • 9.2.4 Over-the-Counter (OTC) Medicines
  • 9.3 Food & Beverages
    • 9.3.1 Fresh Produce
    • 9.3.2 Meat, Poultry, and Seafood
    • 9.3.3 Dairy Products
    • 9.3.4 Ready-to-Eat Meals
  • 9.4 Chemicals
  • 9.5 Other End Users

10 Global Temperature-Controlled Packaging Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Pelican BioThermal (Peli BioThermal)
  • 12.2 Sonoco ThermoSafe
  • 12.3 Cold Chain Technologies
  • 12.4 Cryopak
  • 12.5 va-Q-tec
  • 12.6 CSafe Global
  • 12.7 Envirotainer
  • 12.8 Sofrigam
  • 12.9 Intelsius (DGP Intelsius)
  • 12.10 Nordic Cold Chain Solutions
  • 12.11 Tower Cold Chain Solutions
  • 12.12 TemperPack
  • 12.13 Sealed Air
  • 12.14 Chill-Pak (Engineered Packaging / Chill-Pak)
  • 12.15 CoolPac
  • 12.16 Pluss Advanced Technologies

List of Tables

  • Table 1 Global Temperature-Controlled Packaging Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Temperature-Controlled Packaging Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Temperature-Controlled Packaging Market Outlook, By Insulated Shippers (2024-2032) ($MN)
  • Table 4 Global Temperature-Controlled Packaging Market Outlook, By Insulated Containers (2024-2032) ($MN)
  • Table 5 Global Temperature-Controlled Packaging Market Outlook, By Refrigerants (2024-2032) ($MN)
  • Table 6 Global Temperature-Controlled Packaging Market Outlook, By Gel Packs (2024-2032) ($MN)
  • Table 7 Global Temperature-Controlled Packaging Market Outlook, By PCMs (Phase Change Materials) (2024-2032) ($MN)
  • Table 8 Global Temperature-Controlled Packaging Market Outlook, By Dry Ice (2024-2032) ($MN)
  • Table 9 Global Temperature-Controlled Packaging Market Outlook, By Liquid Nitrogen (2024-2032) ($MN)
  • Table 10 Global Temperature-Controlled Packaging Market Outlook, By Temperature Monitoring Components (2024-2032) ($MN)
  • Table 11 Global Temperature-Controlled Packaging Market Outlook, By System Type (2024-2032) ($MN)
  • Table 12 Global Temperature-Controlled Packaging Market Outlook, By Active Systems (2024-2032) ($MN)
  • Table 13 Global Temperature-Controlled Packaging Market Outlook, By Passive Systems (2024-2032) ($MN)
  • Table 14 Global Temperature-Controlled Packaging Market Outlook, By Usability (2024-2032) ($MN)
  • Table 15 Global Temperature-Controlled Packaging Market Outlook, By Single-Use/Disposable Systems (2024-2032) ($MN)
  • Table 16 Global Temperature-Controlled Packaging Market Outlook, By Reusable/Returnable Systems (2024-2032) ($MN)
  • Table 17 Global Temperature-Controlled Packaging Market Outlook, By Temperature Range (2024-2032) ($MN)
  • Table 18 Global Temperature-Controlled Packaging Market Outlook, By Frozen (<= -15°C to -25°C) (2024-2032) ($MN)
  • Table 19 Global Temperature-Controlled Packaging Market Outlook, By Chilled (2°C to 8°C) (2024-2032) ($MN)
  • Table 20 Global Temperature-Controlled Packaging Market Outlook, By Ambient (15°C to 25°C) (2024-2032) ($MN)
  • Table 21 Global Temperature-Controlled Packaging Market Outlook, By Cryogenic (<=-150°C) (2024-2032) ($MN)
  • Table 22 Global Temperature-Controlled Packaging Market Outlook, By End User (2024-2032) ($MN)
  • Table 23 Global Temperature-Controlled Packaging Market Outlook, By Healthcare & Pharmaceuticals (2024-2032) ($MN)
  • Table 24 Global Temperature-Controlled Packaging Market Outlook, By Clinical Trials (2024-2032) ($MN)
  • Table 25 Global Temperature-Controlled Packaging Market Outlook, By Biologics and Specialty Drugs (2024-2032) ($MN)
  • Table 26 Global Temperature-Controlled Packaging Market Outlook, By Vaccines (2024-2032) ($MN)
  • Table 27 Global Temperature-Controlled Packaging Market Outlook, By Over-the-Counter (OTC) Medicines (2024-2032) ($MN)
  • Table 28 Global Temperature-Controlled Packaging Market Outlook, By Food & Beverages (2024-2032) ($MN)
  • Table 29 Global Temperature-Controlled Packaging Market Outlook, By Fresh Produce (2024-2032) ($MN)
  • Table 30 Global Temperature-Controlled Packaging Market Outlook, By Meat, Poultry, and Seafood (2024-2032) ($MN)
  • Table 31 Global Temperature-Controlled Packaging Market Outlook, By Dairy Products (2024-2032) ($MN)
  • Table 32 Global Temperature-Controlled Packaging Market Outlook, By Ready-to-Eat Meals (2024-2032) ($MN)
  • Table 33 Global Temperature-Controlled Packaging Market Outlook, By Chemicals (2024-2032) ($MN)
  • Table 34 Global Temperature-Controlled Packaging Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.